CeliaRx Review: Peptides Sold Per Fill, Not Per Month

The one-sentence version

CeliaRx is an à-la-carte peptide shop — eight categories, no monthly plan — and the products this board cares about are priced individually and up front: NAD+ $399, sermorelin $349, PT-141 $349, each a one-time fill, plus a separate $55 one-time onboarding consultation. It publishes a 503A claim on its own site, the top rung of our pharmacy test, but routes prescribing through a named third-party telemedicine group rather than its own clinicians. It grades B, 10 points out of 14, computed from published terms alone.

What it is, and who it's for

CeliaRx organizes its catalogue into eight categories — Longevity, Immunity, Weight & Metabolism, Skin & Hair, Gut Health, Brain Health, Performance & Recovery, and Libido — and sells within each one product at a time rather than a bundled monthly membership. That is a genuinely different shape from most of the field we rank: there is no "starting at" floor to decode, because every listed item already carries its real price.

The buyer this suits is someone who wants one specific peptide — say, NAD+ alone — without being sold a recurring plan to get it. The buyer it does not suit is someone comparing month-to-month cost against CoreAge Rx, HealthRX or RxSpan MD, because there is no monthly figure to put next to theirs.

What it actually costs

Verified live on celia-rx.com, 4 August 2026. NAD+ injectable: $399. Sermorelin injectable: $349. PT-141 (bremelanotide) nasal spray: $349. Each is a one-time per-fill charge, not a subscription — refill cadence and any repeat-order pricing are not published on the pages we checked. A separate, one-time $55 Celia Onboarding Consultation (15 minutes) applies before any prescription and is billed apart from the product price.

Our rubric credits a provider for publishing one all-in figure before a reader commits — CeliaRx clears that bar on the product price itself, which is why it scores full marks on price transparency despite the structure being unfamiliar. What it does not clear is the consult test: because the $55 review is billed as its own separate line rather than folded into the product price, it scores zero there, the same way this board scores any provider that states a consult fee sits on top of the medication rather than inside it.

Clinical oversight and the pharmacy

Prescribing at CeliaRx runs through a named third-party telemedicine group, Qualiphy, rather than CeliaRx's own clinical staff — worth knowing, because it is a different trust model than a provider that reviews intakes with its own named physicians. The dispensing pharmacy is described only as "a long-established, full-service pharmacy operating since 1991"; the facility itself is not named, but the site states directly that its products are "503A fulfilled," a claim published on a surface CeliaRx controls. Under how we grade, that clears the top rung of our pharmacy test even without a facility name — the same standard applied to every row we grade. A LegitScript badge is displayed, and the pharmacy is described as licensed to serve patients in all 49 U.S. states, with specific exclusions confirmed only at intake.

The evidence behind what it sells

CeliaRx's Brain Health category is the closest thing on this board's unmonetized field to a cognition-specific claim — but neither NAD+ nor sermorelin has a completed human trial showing a cognitive or focus benefit. The 2026 PRISMA-guided systematic review of NAD+ for anti-aging and wellness screened 113 studies including 33 human intervention trials and found effects on functional, metabolic and vascular outcomes "heterogeneous and often null or endpoint-specific," with clinical effectiveness inconclusive¹. Sermorelin's evidence is thinner still: the trial testing this exact protocol — nightly GHRH 1-29 for six weeks in eleven healthy men aged 64–76 — raised nocturnal growth hormone but produced no change in IGF-1 and no change in DEXA-measured muscle or fat². See NAD+ for longevity and peptides for longevity for the fuller record.

Where it's weak, and who should skip it

Skip it if you want a monthly price to compare — there isn't one, by design. Skip it if you want your own clinician relationship rather than a routed third-party review through Qualiphy. If you proceed, budget the $55 consultation on top of whatever you order, and ask about repeat-fill pricing before assuming the first price is the ongoing one.

The verdict, against the rubric

Our rubric scores five things out of fourteen: price transparency (4), a genuine longevity line (4), clinical oversight (2), pharmacy disclosure (2) and human support (2). CeliaRx takes the full four for publishing real per-fill prices, four for a genuine longevity/peptide catalogue, two for its 503A claim — and zero on clinical oversight, because the consult is billed separately, and zero on human support, which is not stated as included. Ten of fourteen: a B. Three neighbours added the same day are our EdgeRx review, Nolu review and FORM (by GBY) review; the full field is at our provider rankings.